Cargando…

CELF1 promotes matrix metalloproteinases gene expression at transcriptional level in lens epithelial cells

BACKGROUND: RNA binding proteins (RBPs)-mediated regulation plays important roles in many eye diseases, including the canonical RBP CELF1 in cataract. While the definite molecular regulatory mechanisms of CELF1 on cataract still remain elusive. METHODS: In this study, we overexpressed CELF1 in human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Jun, Tian, Xin, Jin, Siyan, He, Yanhui, Song, Meijiao, Zou, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922852/ https://www.ncbi.nlm.nih.gov/pubmed/35287612 http://dx.doi.org/10.1186/s12886-022-02344-8

Ejemplares similares

Altered CELF1 binding to target transcripts in malignant T cells
por: Bohjanen, Paul R., et al.
Publicado: (2015)

Mycoplasma pneumoniae downregulates RECK to promote matrix metalloproteinase-9 secretion by bronchial epithelial cells
por: Qin, Lianmei, et al.
Publicado: (2022)

Matrix metalloproteinase-2 and -9 activities in the human lens epithelial cells and serum of steroid induced posterior subcapsular cataracts
por: Alapure, Bhagwat V., et al.
Publicado: (2012)

High-Throughput Transcriptomics of Celf1 Conditional Knockout Lens Identifies Downstream Networks Linked to Cataract Pathology
por: Siddam, Archana D., et al.
Publicado: (2023)

Evaluation of collagen derived antiangiogenic factors and matrix metalloproteinases in anterior lens epithelial cells of pediatric eyes with persistent fetal vasculature
por: Gajjar, Devarshi U, et al.
Publicado: (2019)

CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT
por: Chaudhury, Arindam, et al.
Publicado: (2016)

Repression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy
por: Berger, Dara S., et al.
Publicado: (2012)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

IL-12-mediated transcriptional regulation of matrix metalloproteinases
por: Roupakia, Eugenia, et al.
Publicado: (2018)

Homeobox A10 promotes the proliferation and invasion of bladder cancer cells via regulation of matrix metalloproteinase-3
por: Liu, Chunlei, et al.
Publicado: (2019)

Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2010)

The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Identification of CELF splicing activation and repression domains in vivo
por: Han, Jin, et al.
Publicado: (2005)

The RNA-binding protein Celf1 post-transcriptionally regulates p27(Kip1) and Dnase2b to control fiber cell nuclear degradation in lens development
por: Siddam, Archana D., et al.
Publicado: (2018)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Immunohistochemical Correlation of Matrix Metalloproteinase-2 and Tissue Inhibitors of Metalloproteinase-2 in Tobacco Associated Epithelial Dysplasia
por: Bajracharya, Dipshikha, et al.
Publicado: (2014)

RNA-binding protein CELF6 modulates transcription and splicing levels of genes associated with tumorigenesis in lung cancer A549 cells
por: Ma, HuSai, et al.
Publicado: (2022)

Smart Contact Lens with Dual‐Sensing Platform for Monitoring Intraocular Pressure and Matrix Metalloproteinase‐9
por: Ye, Ying, et al.
Publicado: (2022)

Epilysin (matrix metalloproteinase-28) contributes to airway epithelial cell survival
por: Manicone, Anne M, et al.
Publicado: (2011)

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
por: Qiao, Zhen-kui, et al.
Publicado: (2013)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Celf1 Is Required for Formation of Endoderm-Derived Organs in Zebrafish
por: Tahara, Naoyuki, et al.
Publicado: (2013)

Association of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese population
por: Guo, Yun-Miao, et al.
Publicado: (2015)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
por: Zhong, Ting-Ting, et al.
Publicado: (2021)

Reciprocal regulation of hnRNP C and CELF2 through translation and transcription tunes splicing activity in T cells
por: Mallory, Michael J, et al.
Publicado: (2020)

Wnt3a promotes epithelial–mesenchymal transition, migration, and proliferation of lens epithelial cells
por: Bao, Xiu-li, et al.
Publicado: (2012)

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1
por: Zhao, Xiu-lan, et al.
Publicado: (2011)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B
por: Xia, Liang, et al.
Publicado: (2015)

Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration
por: Zeng, Renpan, et al.
Publicado: (2013)

Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2020)

Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis
por: Jones, Tiffanie K., et al.
Publicado: (2022)

Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus
por: Yürük Yıldırım, Zeynep, et al.
Publicado: (2019)

Matrix Metalloproteinases and the Pathogenesis of Recurrent Corneal Erosions and Epithelial Basement Membrane Dystrophy
por: Jadczyk-Sorek, Katarzyna, et al.
Publicado: (2023)

Interleukin-10 control of pre-miR155 maturation involves CELF2
por: Yoon, Jeff S. J., et al.
Publicado: (2020)

Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins
por: Wang, Eric T., et al.
Publicado: (2015)

Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1
por: Giudice, Jimena, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_de1ndtgk6h4okt4poiap4nn371